Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, LIC, MAT

CBD Naturals® Vendor Partner Adopts Innovative Low-Temp Hemp Extraction Technology


CARLSBAD, Calif., June 21, 2018 /PRNewswire/ -- CBD Naturals® strategic vendor partner NanoSphere Technologies has recently launched a revolutionary process for extracting phytocannabinoids and other full-spectrum constituents from hemp. This process provides an efficient, low-temp method for "live resin" extracts that preserve 100 percent of the natural phytocannabinoids, terpinoids and flavinoids, previously unheard of in the industry.

(PRNewsfoto/CBD Naturals)

NanoSphere Technologies creates extracts from high-quality natural raw products that haven't been altered by heat. The resulting "live resin" from this breakthrough technology, preserves all constituents of the plant by extracting at room temperature, nearly eliminating degradation caused by typical processing. In addition, this innovative technology eliminates multiple steps, with no need for winterization, filtration and evaporation, delivering true full-spectrum oil right after extraction.

"As NanoSphere Technologies has continued to lead the way in the industry, we have enjoyed this strong partnership and appreciated their premier science and technology when it comes to extraction. Leveraging this breakthrough extraction method for our family of brands is the perfect next step in this growing relationship," said Jared Berry, founder and CEO of CBD Naturals® and founder of Isodiol, which now share a strategic partnership.

"Working with the visionary leadership at CBD Naturals has enabled our company to further our research into groundbreaking technology, resulting in greater purity, quality and visibility in the industry," said Josh Franks, VP of Operation at NanoSphere Technologies. "We are excited to be a part of bringing a new standard in true full-spectrum hemp extracts to market."

About CBD Naturals®
Launched in 2011 by industry trailblazer Jared Berry, CBD Naturals® has logged an impressive list of industry firsts, including becoming the first CBD brand to ever be filed with the USPTO for trademark. Prior to filing for this intellectual property, a "CBD marketplace" didn't exist, marking Berry and his team of scientists the original trailblazers of the space. CBD Naturals® continues to pioneer scientific advancements in uncovering the full wellness potential of the cannabis plant. Using proprietary technology and industry leadership, they aim to bring the nutritional benefits of this plant to those interested in living a healthier life. For more information, please visit https://cbdnaturals.com/ 

Contact:
Logan Lidster 
[email protected] 
844-877-7908

 

SOURCE CBD Naturals


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: